SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and social media users weigh in on controversial reports regarding an Iran-related memorandum of understanding. The community remains deeply polarized, with active discussions focusing on the perceived impact of the deal, the company's financial performance, and wider political developments involving the current administration.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending as traders closely watch the stock test the psychological resistance level of 100 amid increased retail interest and recent corporate workforce restructuring. The community is actively debating the company's ability to maintain momentum and capture rising volumes from its prediction markets and expanded financial services, with many closely watching for a breakout confirmation.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is currently trending as investors debate its valuation amid aggressive AI infrastructure spending and its complex relationship with Anthropic's recent regulatory export hurdles. The community is actively discussing the company's long-term compounding potential, with many highlighting AWS as a key catalyst while debating the stock's recent performance compared to high-profile IPOs and broader market trends.

Rackspace Technology, Inc. engages in the provision of end-to-end multi-cloud technology services. The firm designs, builds and operates its customers’ cloud environments across technology platforms. It operates through the following segments: Multicloud Services and Apps & Cross Platform. The Multicloud Services segment includes public and private cloud managed services offerings, as well as professional services related to designing and building multicloud solutions and cloud-native applications. The Apps & Cross Platform segment includes managed applications, managed security and data services, as well as professional services related to designing and implementing application, security and data services. The company was founded on July 21, 2016 and is headquartered in San Antonio, TX.

Rackspace Technology Inc

Rackspace Technology is trending following a significant partnership announcement with AMD to deploy AI compute infrastructure, alongside strategic workforce restructuring aimed at boosting long-term profitability. Investors are heavily debating the stock's potential for a breakout, with many in the community looking for double-digit price targets as they monitor for potential short squeeze signals.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy is seeing significant investor interest driven by strong quarterly performance, the upcoming commissioning of its second production line, and a strategic partnership with Frontier Power USA that enhances its project backlog. The community is actively discussing the stock's high short interest and its potential as a critical player in the AI infrastructure and grid-scale energy storage sector, with many focused on long-term accumulation despite current volatility.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as investors brace for a potential cascade of data readouts, including highly anticipated Phase 3 results and secondary trial updates, fueling speculation of an imminent rerating or strategic M&A event. Community discourse remains focused on the company's best-in-class science versus broader market manipulation, with heavy emphasis on institutional accumulation patterns ahead of near-term milestones.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as shareholders react to an expedited legal battle against Nippon Shinyaku, with the community closely monitoring the court's upcoming remand decision to see if the company can reclaim independent distribution rights ahead of its late-August FDA PDUFA date. Investors remain highly optimistic about the drug's long-term commercial potential, viewing current price volatility as a buying opportunity while emphasizing the critical need for FDA approval to address the urgent medical needs of DMD patients.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure is experiencing extreme volatility and intense community debate following an FDA decision to require a new, placebo-controlled study for its Huntington's disease gene therapy. Investors are actively discussing the potential for regulatory pushback, the impact of high-profile FDA leadership changes on biotech pathways, and the stock's significant price swing as bulls argue the company remains undervalued relative to its cash position and long-term potential.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta is facing intense selling pressure as investors grapple with negative sentiment surrounding its high AI infrastructure spending and concerns over corporate leadership, leading many to pivot between defensive positioning and tactical shorting. The community remains deeply divided, with some actively trading the stock's volatility while others express frustration over the lack of sustained price recovery and persistent, market-lagging performance.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna shares are trending as the community debates the company's potential role in addressing emerging health threats, while simultaneously focusing on its upcoming pipeline presentations at ASCO and a key FDA advisory meeting regarding its flu vaccine. Investors are actively discussing the stock's volatility, weighing recent organizational shifts and long-term oncology prospects against concerns over institutional short positions and regulatory headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are Finance Stocks Lagging  Adamas Trust, Inc. (ADAM) This Year?

Here is how Adamas Trust (ADAM) and Bankwell Financial Group, Inc. (BWFG) have performed compared to their sector so far this year.

Is Adamas Trust, Inc. (ADAM) Stock Outpacing Its Finance Peers This Year?

Here is how Adamas Trust (ADAM) and Accelerant Holdings (ARX) have performed compared to their sector so far this year.

397,986 Shares in Adamas Trust, Inc. $ADAM Bought by Wolverine Asset Management LLC

Wolverine Asset Management LLC acquired a new position in shares of Adamas Trust, Inc. (NASDAQ:ADAM - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 397,986 shares of the company's stock, val...

Adamas Trust (NASDAQ:ADAM) Reaches New 12-Month High  - Here's What Happened

Adamas Trust (NASDAQ:ADAM) Sets New 1-Year High - Here's Why...

Adamas Trust (ADAM) Q1 2026 Earnings Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Noteworthy Thursday Option Activity: ADAM, GME, CC

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Adamas Trust Inc (Symbol: ADAM), where a total volume of 11,975 contracts has been traded thus far today, a contract volume which is representative of approximat...

Adamas Trust (NASDAQ:ADAM) Earns Neutral Rating from B. Riley Financial

B. Riley Financial reaffirmed a "neutral" rating and set a $9.50 target price on shares of Adamas Trust in a research report on Thursday...

Adamas Trust (NASDAQ:ADAM) Trading Up 14% After Better-Than-Expected Earnings

Adamas Trust (NASDAQ:ADAM) Trading 14% Higher Following Earnings Beat...

Adamas Trust Reports Q1 2026 Results: Full Earnings Call Transcript

Adamas Trust (ADAM) Q1 Earnings and Revenues Top Estimates

Adamas Trust (ADAM) delivered earnings and revenue surprises of +20.83% and +21.03%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Adamas Trust, Inc. is a real estate investment trust, which engages in the acquisition, investment, finance, and management of mortgage-related single-family and multi-family residential assets. Its investment portfolio includes credit sensitive single-family and multi-family assets. The company was founded on September 26, 2003 and is headquartered in New York, NY.

Adamas Trust Inc.

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$9.26
Prev Close	$9.36
Open	$9.31
Dividend Yield	11.78%
50-Day Moving Average	$8.56
Beta	0.97
Avg. Volume	741,631.43
PE Ratio	7.99

52-Week High	$9.52
52-Week Low	$6.16
Market Capitalization	$841.1M
EPS (Annual)	$1.10
Price to Book	0.92
Revenue Per Employee	$3.04M

ADAMAdamas Trust Inc.

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ADAM News